Insights & Resources – COD Research – Designing Therapies For Future

The Evolution of PRO Collection: From Paper Diaries to ePRO Systems

Transforming Complexity into Success: A Large-Scale Global Phase III Biosimilar Dermatology Trial

Biometrics

Clinical Services

CT Quality Assurance

Medical Affairs

Pulmonary Disease Introduction: Prevalence, Causes, Prevention & Treatment

Strategic Planning for Patient Recruitment

EMA
FDA
MHRA

Name Review Group (NRG) plenary meeting dates: 2026-2027
Source: EMA Published on 2026-08-10
Article 57 product data
Source: EMA Published on 2026-08-10
European Medicines Agency’s data protection notice for committees, Working Parties (WPs), Scientific Advisory Groups (SAGs) and Ad-Hoc Expert Groups (AHEGs)
Source: EMA Published on 2026-08-10
Minutes of the COMP meeting 16-18 June 2026
Source: EMA Published on 2026-08-10
Recommendations on eligibility to PRIME scheme - Adopted at the CHMP meeting of 20-23 July 2026
Source: EMA Published on 2026-08-10
List of medicines currently in PRIME scheme
Source: EMA Published on 2026-08-10

Read More